HER2, Breast Cancer and PFS
Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...
1d
News Medical on MSNIgE antibodies show promise in targeting HER2 cancers resistant to other therapiesAntibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly being investigated as an alternative for chemotherapy and radiotherapy.
A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.
OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has been awarded a ...
OS Therapies (OSTX) announced that it has scheduled a Scientific Advice Meeting in the third quarter of 2025 to discuss the Innovative ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results